Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)
Bendroflumethiazide
Advanz Pharma
C03AA01
Bendroflumethiazide
2.5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02020100; GTIN: 5021691110095
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT NEO-NACLEX®-K 2.5MG/630MG TABLETS BENDROFLUMETHIAZIDE AND POTASSIUM CHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any of the side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. This product is called NEO-NACLEX®-K 2.5mg/630mg TABLETS. It will be referred to as NEONACLEX® for ease hereafter. WHAT IS IN THIS LEAFLET: 1. What NEO-NACLEX® is and what it isused for 2. What you need to know before you take NEO-NACLEX® 3. How to take NEO-NACLEX® 4. Possible side effects 5. How to store NEO-NACLEX® 6. Contents of the pack and other information 1. WHAT NEO-NACLEX® IS AND WHAT IT IS USED FOR NEO-NACLEX® belong to a group of medicines called diuretics. They make the kidneys remove water from the body. NEO-NACLEX® are used to treat: • Oedema, which is a build-up of fluid in the body. This may occur in many situations, for instance with liver and kidney problems or with heart failure (when the heart doesn’t pump efficiently) • Raised blood pressure (hypertension). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NEO-NACLEX® DO NOT TAKE NEO-NACLEX® • if you are allergic to bendroflumethiazide or potassium chloride or any of the other ingredients of this medicine (listed in section 6). • have a serious liver or kidney disorder (your doctor will advise you) • have high levels of potassium (hyperkalaemia) or calcium (hypercalcaemia) in your blood. Your doctor will advise you • suffer from serious complications from diabetes (diabetic keto-acidosis) • have a disease of the adrenal glands causing weakn Perskaitykite visą dokumentą
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Neo-Naclex-K 2.5mg/630mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.5mg Bendroflumethiazide in the white layer and 630mg Potassium chloride in the pink layer, providing 330mg elemental potassium (8.4 mEq). 3. PHARMACEUTICAL FORM Film coated, two-layered white and pink tablet. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Essential hypertension _ The mechanism whereby the thiazides exert their antihypertensive effect has not been clearly established. In non-oedematous patients there may be little noticeable diuretic effect. Neo-Naclex-K may be used as the sole anti- hypertensive agent, or as an adjunct to other anti-hypertensive drugs whose action may be enhanced. _Oedema. _ Neo-Naclex-K inhibits the renal tubular absorption of salt and water by its action at the beginning of the distal convoluted tubule. Sodium and chloride ions are excreted in equivalent proportions. Because potassium excretion is promoted, metabolic alkalosis may occur secondary to hypokalaemia. There is no important effect upon carbonic anhydrase. Neo-Naclex-K causes a steady diuresis lasting about 12 hours. It is indicated in the treatment of oedema associated with conditions such as congestive heart failure, nephrotic syndrome and cirrhosis of the liver. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults: When Neo-Naclex-K is added to other antihypertensive drugs, the dosage of the latter can usually be reduced as the Neo-Naclex-K takes effect. _Essential hypertension _ 1 tablet once daily, alone or in conjunction with other anti-hypertensive agents. _Oedema: _ 2 tablets once daily in the morning usually produce the desired effect without diuresis interfering with sleep. The dose can be increased to 4 tablets, if required. During the first few days of treatment, there is usually a large increase in urinary volume, which diminishes as treatment continues. Maintenance-Many patients will respond adequately to a daily dose of 1 to 2 t Perskaitykite visą dokumentą